TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis.

TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis.

Publication date: Mar 23, 2020

Located on chromosome locus 5p15.33, telomerase reverse transcriptase (TERT or hTERT) encodes the catalytic subunit of telomerase which permits lengthening and preservation of telomeres following mitosis. Mutations in TERT promoter (TERT-p) upregulate expression of TERT, allowing survival of malignant cells and tumor progression in wide variety of malignancies including melanoma. The objective of this review is to examine the roles of TERT and TERT-p in the pathogenesis, diagnosis, and prognostication of cutaneous melanoma.

All studies of TERT or TERT-p in cutaneous melanocytic neoplasms with the following inclusion criteria were reviewed: publication date between 2010-2019, English language, and series of ?3 cases were reviewed for evidence supporting the role of TERT in pathogenesis, diagnosis, and prognosis prognosis. Studies with

Motaparthi, K., Kim, J., Andea, A.A., Missall, T.A., Novoa, R.A., Vidal, C.I., Fung, M.A., and Emanuel, P.O. TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis. 26207. 2020 J Cutan Pathol.

Concepts Keywords
Catalytic Branches of biology
Chromosome Telomeres
HTERT Melanoma
Locus DNA replication
Malignancies Ribonucleoproteins
Malignant Tumor Senescence
Melanoma Telomerase
Mitosis Nucleic acids
Neoplasms
Pathogenesis
Prognosis
Telomerase
Telomerase Reverse Transcriptase
Telomeres
TERT

Semantics

Type Source Name
disease MESH neoplasms
disease MESH diagnosis
disease MESH melanoma
pathway KEGG Melanoma

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *